Medtech, a company specialized in designing, developing and marketing surgical assistance robots, has announced the first U.S. procedure using ROSA Spine was performed at Miami Valley Hospital in Dayton, Ohio. Miami Valley Hospital was the first site to acquire ROSA Spine in the United States following the product's clearance by the U.S. Food and Drug Administration (FDA) in January 2016.
The operation was performed by Dr. Juan Torres-Reveron, a neurosurgeon at Miami Valley Hospital. The patient presented symptoms associated with ongoing lumbar and leg pain and was treated with a spinal fusion procedure utilizing ROSA Spine.
“Premier Health has long been bringing these advanced technologies to patients," said Mark Shaker, president and CEO of Miami Valley Hospital. "We are extremely proud of our team of clinicians including physicians, nurses, other professionals, and support staff all working together to provide this level of care for the region."
ROSA Spine received the CE Mark in 2014. Medtech’s ROSA Brain received FDA approval in 2012 and is currently in use in 29 U.S. facilities.
“We are proud to officially have ROSA Spine in use in the U.S.,” said Bertin Nahum, CEO and founder of Medtech. “This technology allows surgeons to perform minimally invasive surgical procedures on the spine and increases the safety and reliability of the operations. The American market is the world’s leading market for spinal surgery, and this expansion will allow us to benefit a greater number of patients.”
Founded in 2002, Medtech is based in Montpellier, France.